Sandoz Group AG announced that Graeme Pitkethly, Deputy Chair and Senior Independent Director of Pearson, was appointed to the Board of Sandoz Group AG as Non-Executive Director and Chair of its Audit, Risk and Compliance Committee with effect from 30 April 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.99 CHF | -0.87% | -1.72% | +18.22% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.22% | 15.33B | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.66B | |
+6.11% | 4.85B |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Sandoz Group AG Announces Appointment of Graeme Pitkethly as Non-Executive Director and Chair of Its Audit, Risk and Compliance Committee